Venetoclax in combination with antibodies in the treatment of CLL
An overview on NK/T-cell lymphoma treatment
Won Seog Kim
Ibrutinib and ublituximab – a promising combination regimen for treating CLL?
Novel venetoclax combination therapy advancing the field of CLL
CLL2-GIVe trial: investigating chemotherapy-free treatment of CLL